Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. Fluids are given when someone's body fluid volume falls. There are a number of things which can cause a drop in fluid volume. Intravenous fluids can be broken into two broad groups. Crystalloids such as saline solutions contain a solution of molecules which can dissolve in water.
· Treatment of discarded water and electrolyte metabolism, especially in severe cases.
· Therapy of acid base in balances.
· The volume substitution and volume replacement in surgery of accident victim suffering blood loss.
· Paratral nutrition for severally ill and post-operative patients.
· Dextrose solution is used during postoperative period when sodium extraction is reduced.
The global intravenous solutions market size is expected to reach USD 18.9 billion by 2028, the market is expected to expand at a CAGR of 7.9% from 2021 to 2028. The growing incidence rate of chronic diseases such as cancer, increase in the number of premature births, and shortage of I.V. solutions in the U.S. are some of the key factors expected to drive the market. One of the prime areas wherein intravenous (IV) fluids find usage is severe dehydration. Severe dehydration is seen in diseases such as diarrhea, resulting in the depletion of fluids from the body. The ongoing COVID-19 pandemic is expected to have a positive impact on the market. Intensive Care Units (ICU) worldwide are either operating at full capacity or are overcrowded due to the high influx of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).